|
Light |
Human bladder (T24) spheroids |
A cathepsin B-sensitive polymer-paclitaxel (PTX) prodrug and the photosensitizer chlorin e6 (Ce6) loaded into NPs (poly(OEGMA)-PTX@Ce6) |
Ce6 released into the T24 spheroids and then light irradiated produced ROS. The PTX was also released by cathepsin B, determining anticancer effect |
[58] |
Rat C6 glioma cell line (C6 MCS) |
Targeted Micellar Nanoprobe (TMNP) with exceptionally high encapsulation efficiencies of a hydrophobic drug simvastatin (SV) and a photosensitizer protoporphyrin IX (PpIX) |
TMNP under light irradiation showed huge amount of ROS production and induction in apoptotic and necrotic pathways |
[73] |
Temperature |
Human cervical (HeLa) spheroids |
Doxorubicin-loaded gold-core silica-shell nanorods with salicylic acid-loaded poly (lactic-co-glycolic acid)-based microparticles (NIMPS) |
Uniform doxorubicin distribution under NIR irradiation along with spheroid surface disorganization |
[74] |
Adenocarcinomic human alveolar basal epithelial (A549) spheroids |
Low temperature-sensitive liposomes (LTSLs) loaded with doxorubicin |
Combination between LTSLs and mild hyperthermia induced reduction in spheroid viability |
[75] |
Ultrasound |
Human breast cancer spheroids (MCF-7) |
Microbubbles loaded with rose bengal, paclitaxel, and doxorubicin (O2MB-PTX-Dox/O2MB-PTX-RB) |
MCF-7 spheroid volume reduction and increase in necrotic cells under sonodynamic exposure of O2MB-PTX-Dox/O2MB-PTX-RB |
[80] |
Human pancreatic (BxPC-3) spheroids |
Gemcitabine-modified phospholipid incorporated into a single microbubble formulation loaded with PTX (Lipid-Gem-PTX MB) |
A statistically significant reduction in BxPC-3 spheroid volume was observed when spheroids underwent to US exposure of Lipid-Gem-PTX MB |
[82] |
Magnetic |
On-chip system |
Magnetic NPs (MNPs) |
Particles with a diameter size between 10 and 100 μm displayed the similar trend |
[85] |
Microfluidic chip |
Magnetic NPs (MNPs) |
MNPs showed highly spherical shape and superparamagnetic properties in the system |
[86] |